Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension

被引：52

作者：

Halank, M ^{[1
]}

Miehlke, S ^{[1
]}

Hoeffken, G ^{[1
]}

Schmeisser, A ^{[1
]}

Schulze, M ^{[1
]}

Strasser, RH ^{[1
]}

机构：

[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med, D-8027 Dresden, Germany

来源：

TRANSPLANTATION | 2004年 / 77卷 / 11期

关键词：

D O I：

10.1097/01.TP.0000122420.86904.89

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1775 / 1776

页数：2

共 4 条

[1] Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study [J].

Channick, RN ;

Simonneau, G ;

Sitbon, O ;

Robbins, IM ;

Frost, A ;

Tapson, VF ;

Badesch, DB ;

Roux, S ;

Rainisio, M ;

Bodin, F ;

Rubin, LJ .

LANCET, 2001, 358 (9288) :1119-1123

[2] The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver [J].

Reichen, J ;

Gerbes, AL ;

Stainer, MJ ;

Sägesser, H ;

Clozel, M .

JOURNAL OF HEPATOLOGY, 1998, 28 (06) :1020-1030

[3] Bosentan therapy for pulmonary arterial hypertension [J].

Rubin, LJ ;

Badesch, DB ;

Barst, RJ ;

Galiè, N ;

Black, CM ;

Keogh, A ;

Pulido, T ;

Frost, A ;

Roux, S ;

Leconte, I ;

Landzberg, M ;

Simonneau, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :896-903

[4] Beneficial hemodynamic effects of bosentan, a mixed ETA and ETB receptor antagonist, in portal hypertensive rats [J].

Sogni, P ;

Moreau, R ;

Gomola, A ;

Gadano, A ;

Cailmail, S ;

Calmus, Y ;

Clozel, M ;

Lebrec, D .

HEPATOLOGY, 1998, 28 (03) :655-659

← 1 →